80 related articles for article (PubMed ID: 20067113)
1. [Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene].
Wang R; Ciren YJ; Yang JL; Zhang B; Chen JP; Tang CW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1029-32. PubMed ID: 20067113
[TBL] [Abstract][Full Text] [Related]
2. [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
Ran JT; Zhou YN; Tang CW; Li HH; Li XW; Lu H
Ai Zheng; 2009 Apr; 28(4):361-5. PubMed ID: 19622294
[TBL] [Abstract][Full Text] [Related]
3. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
5. Expression and possible role of non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) in the human endometrium and endometriosis.
Seo SK; Nam A; Jeon YE; Cho S; Choi YS; Lee BS
Hum Reprod; 2010 Dec; 25(12):3043-9. PubMed ID: 20937742
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory pathogenesis of prostate cancer and celecoxib.
Mathew P
J Clin Oncol; 2010 Apr; 28(12):e197; author reply e198. PubMed ID: 20177014
[No Abstract] [Full Text] [Related]
8. The anti-cancer effect of COX-2 inhibitors on gastric cancer cells.
Cho SJ; Kim N; Kim JS; Jung HC; Song IS
Dig Dis Sci; 2007 Jul; 52(7):1713-21. PubMed ID: 17393325
[TBL] [Abstract][Full Text] [Related]
9. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
Batu OS; Erol K
Inflammopharmacology; 2007 Dec; 15(6):260-5. PubMed ID: 18236017
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
11. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
12. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
13. Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide.
Huang MT; Chen ZX; Wei B; Zhang B; Wang CH; Huang MH; Liu R; Tang CW
Acta Pharmacol Sin; 2007 Nov; 28(11):1842-50. PubMed ID: 17959037
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effect of celecoxib in gastric cancer.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Sakamoto C
Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis proposes alternative pathways for the mechanism by which celecoxib selectively inhibits the growth of transformed but not normal enterocytes.
Sagiv E; Rozovski U; Kazanov D; Liberman E; Arber N
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6807-15. PubMed ID: 18006783
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells.
Namba T; Hoshino T; Tanaka K; Tsutsumi S; Ishihara T; Mima S; Suzuki K; Ogawa S; Mizushima T
Mol Pharmacol; 2007 Mar; 71(3):860-70. PubMed ID: 17167033
[TBL] [Abstract][Full Text] [Related]
17. A celecoxib derivative potently inhibits proliferation of colon adenocarcinoma cells by induction of apoptosis.
Kusunoki N; Ito T; Sakurai N; Handa H; Kawai S
Anticancer Res; 2006; 26(5A):3229-36. PubMed ID: 17094434
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
19. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
Narayanan BA; Narayanan NK; Pttman B; Reddy BS
Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
